[1]
Hassanzadeh, A. et al. 2024. Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs): bench to bedside. EXCLI Journal. 23, (Jun. 2024), 862–882. DOI:https://doi.org/10.17179/excli2024-7076.